Revision Skincare(R) Announces Two Peer--Reviewed Clinical Studies Demonstrating the Cosmetic Benefits of THD Ascorbate in C+ Correcting Complex 30%(R)

Revision Skincare(R), a physician--dispensed medical--grade skincare company focused on clinically validated innovation, today announced the publication of two peer--reviewed clinical studies in the ...
Everyday Health

What People of Color Should Know About Joining an Atopic Dermatitis Clinical Trial

Learn why representation in atopic dermatitis clinical trials matters for people of color, as well as the benefits, risks, ...
Business Wire

DermTech Study, “Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for ...

LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that ...
European Medical Journal

Skin Cancer Screening Tool Gains Ground in Transplant Care

A new risk stratification tool for skin cancer in solid organ transplant recipients is gaining global validation. Read more.
Hosted on MSN

5 skin signs of liver damage you should not ignore

The liver performs essential functions involving detoxification, hormone regulation and nutrient metabolism, and changes in its performance often become visible on the skin before other symptoms ...